UK-based Oxford VR hopes to paved the way in automated VR remedy sooner or later, and it simply raised £10 million to assist obtain that aim.
The corporate, which span out of Oxford College’s Division of Psychiatry in 2017, raised the cash in a Sequence A spherical of funding led by Optum Ventures. In accordance with a press launch, the brand new funds will “allow Oxford VR to speed up US enlargement of its evidence-based and scalable automated VR remedy answer and to proceed to develop its remedy pipeline.”
Oxford VR is seeking to flip lots of the proposed well being advantages of VR right into a actuality within the coming years. The corporate began out with a scientific trial, testing VR’s capability to deal with a concern of heights. Since those who trial, it’s expanded its providing to sort out areas like OCD and social anxiousness too.
The platform presents automated remedy aligned with scientific requirements and protocol, creating simulated occasions that may set off these points and assist victims confront them in a protected, managed atmosphere. You possibly can see an instance of the corporate’s work tackling a concern of heights in a affected person under.
Presently the corporate is partnering with AXA Hong Kong and The Chinese language College of Hong Kong (CUHK) to convey its work to Asia, whereas a partnership with the Nationwide Psychological Well being Innovation Centre (NMHIC) is doing the identical for the US.
VR’s capability to simulate actuality presents loads of attainable healthcare advantages for the longer term. Past Oxford VR’s choices, we’ve additionally seen surgical coaching platforms like FundamentalVR embrace the know-how.